{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:12:11Z","timestamp":1788199931334,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s40292-020-00368-z","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T12:02:52Z","timestamp":1583841772000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project"],"prefix":"10.1007","volume":"27","author":[{"given":"Alessandro","family":"Maloberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Giannattasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bombelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. F. G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Muiesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Rosei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rivasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pontremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Viazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Facchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bernardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"D\u2019Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Palatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Casiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Tikhonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Verdecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rattazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pauletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nazzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dell\u2019Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Quarti-Trevano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Virdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"368_CR1","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al. 2018 esc\/esh guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"368_CR2","first-page":"611","volume":"9","author":"WB Kannel","year":"1967","unstructured":"Kannel WB, Castelli WP, McNamara PM. The coronary profile: 12-year follow-up in the Framingham study. J Occup Med. 1967;9:611\u20139.","journal-title":"J Occup Med"},{"key":"368_CR3","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992. National Health and nutrition examination survey. JAMA. 2000;283:2404\u201310.","journal-title":"JAMA."},{"key":"368_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2796.2009.02133.x","volume":"266","author":"I Holme","year":"2009","unstructured":"Holme I, Aastveit AH, Hammar N, et al. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009;266:558\u201370.","journal-title":"J Intern Med"},{"key":"368_CR5","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1161\/ATVBAHA.107.160184","volume":"28","author":"C Meisinger","year":"2008","unstructured":"Meisinger C, Koenig W, Baumert J, Doring A. Uric acid levels are associated with all cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA\/KORA cohort study. Arterioscler Thromb Vasc Biol. 2008;28:1186\u201392.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"368_CR6","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/archinte.164.14.1546","volume":"164","author":"LK Niskanen","year":"2004","unstructured":"Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004;164:1546\u201351.","journal-title":"Arch Intern Med"},{"key":"368_CR7","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","volume":"37","author":"MJ Bos","year":"2006","unstructured":"Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke. 2006;37:1503\u20137.","journal-title":"Stroke"},{"issue":"8","key":"368_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.numecd.2018.04.013","volume":"28","author":"C Mancusi","year":"2018","unstructured":"Mancusi C, Izzo R, Ferrara LA, Rozza F, Losi MA, Canciello G, Pepe M, de Luca N, Trimarco B, de Simone G. Is increased uric acid a risk factor or a defensive response? The Campania Salute Network. Nutr Metab Cardiovasc Dis. 2018;28(8):839\u201346.","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"368_CR9","doi-asserted-by":"publisher","first-page":"19520","DOI":"10.1038\/srep19520","volume":"6","author":"M Li","year":"2016","unstructured":"Li M, Hu X, Fan Y, et al. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis. Sci Rep. 2016;6:19520.","journal-title":"Sci Rep"},{"key":"368_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/CIRCHEARTFAILURE.108.797662","volume":"2","author":"E Krishnan","year":"2009","unstructured":"Krishnan E. Hyperuricemia and incident heart failure. Circ Heart Fail. 2009;2:556\u201362.","journal-title":"Circ Heart Fail"},{"key":"368_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijcard.2009.01.010","volume":"142","author":"OJ Ekundayo","year":"2010","unstructured":"Ekundayo OJ, Dell\u2019Italia LJ, Sanders PW, et al. Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol. 2010;142:279\u201387.","journal-title":"Int J Cardiol"},{"key":"368_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1751-7133.2011.00200.x","volume":"17","author":"L Tamariz","year":"2011","unstructured":"Tamariz L, Harzand A, Palacio A, et al. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congest Heart Fail. 2011;17:25\u201330.","journal-title":"Congest Heart Fail."},{"key":"368_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","volume":"16","author":"H Huang","year":"2014","unstructured":"Huang H, Huang B, Li Y, et al. Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2014;16:15\u201324.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"368_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.amjcard.2005.04.007","volume":"96","author":"S Kojima","year":"2005","unstructured":"Kojima S, Sakamoto T, Ishihara M, Japanese Acute Coronary Syndrome Study (JACSS) Investigators, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol. 2005;96(4):489\u201395.","journal-title":"Am J Cardiol."},{"issue":"2","key":"368_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijcard.2008.06.024","volume":"138","author":"C Lazzeri","year":"2010","unstructured":"Lazzeri C, Valente S, Chiostri M, et al. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol. 2010;138(2):206\u20139.","journal-title":"Int J Cardiol"},{"issue":"1","key":"368_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12872-017-0660-9","volume":"17","author":"R Wang","year":"2017","unstructured":"Wang R, Mei B, Liao X, et al. Determination of risk factors affecting the in-hospital prognosis of patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention. BMC Cardiovasc Disord. 2017;17(1):243.","journal-title":"BMC Cardiovasc Disord."},{"key":"368_CR17","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.amjcard.2011.06.043","volume":"108","author":"L Tamariz","year":"2011","unstructured":"Tamariz L, Agarwal S, Soliman EZ, et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol. 2011;108:1272\u20136.","journal-title":"Am J Cardiol"},{"issue":"7","key":"368_CR18","doi-asserted-by":"publisher","first-page":"005354","DOI":"10.1136\/bmjopen-2014-005354","volume":"4","author":"TM MacDonald","year":"2014","unstructured":"MacDonald TM, Ford I, Nuki G, Members of the FAST Study Group, et al. Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia. BMJ Open. 2014;4(7):005354.","journal-title":"BMJ Open."},{"issue":"22","key":"368_CR19","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/eurheartj\/ehz119","volume":"40","author":"S Kojima","year":"2019","unstructured":"Kojima S, Matsui K, Hiramitsu S, et al. Febuxostat for cerebral and caRdiorenovascular events PrEvEntion StuDy (FREED) investigators. Eur Heart J. 2019;40(22):1778\u201386.","journal-title":"Eur Heart J"},{"issue":"9","key":"368_CR20","doi-asserted-by":"publisher","first-page":"e013774","DOI":"10.1136\/bmjopen-2016-013774","volume":"6","author":"IS Mackenzie","year":"2016","unstructured":"Mackenzie IS, Ford I, Walker A, ALL-HEART study group, et al. Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study. BMJ Open. 2016;6(9):e013774.","journal-title":"BMJ Open."},{"key":"368_CR21","first-page":"1295","volume":"18","author":"G Desideri","year":"2014","unstructured":"Desideri G, Castaldo G, Lombardi A, et al. Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci. 2014;18:1295\u2013306.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"368_CR22","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","volume":"36","author":"P Verdecchia","year":"2000","unstructured":"Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension. 2000;36:1072\u20138.","journal-title":"Hypertension"},{"issue":"32","key":"368_CR23","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145\u201351.","journal-title":"Curr Pharm Des"},{"key":"368_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/jhh.2016.48","volume":"31","author":"L Liu","year":"2017","unstructured":"Liu L, Gu Y, Li C, et al. Serum uric acid is an independent predictor for developing prehypertension: a population-based prospective cohort study. J Hum Hypertens. 2017;31:116\u201320.","journal-title":"J Hum Hypertens"},{"key":"368_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1097\/00004872-200107000-00005","volume":"19","author":"Y Taniguchi","year":"2001","unstructured":"Taniguchi Y, Hayashi T, Tsumura K, et al. Serumuric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens. 2001;19:1209\u201315.","journal-title":"J Hypertens"},{"key":"368_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/met.2012.0151","volume":"11","author":"K Osgood","year":"2013","unstructured":"Osgood K, Krakoff J, Thearle M. Serum uric acid predicts both current and future components of the metabolic syndrome. Metab Syndr Relat Disord. 2013;11:157\u201362.","journal-title":"Metab Syndr Relat Disord."},{"issue":"3","key":"368_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40292-014-0042-7","volume":"21","author":"F Viazzi","year":"2014","unstructured":"Viazzi F, Leoncini G, Ratto E, Pontremoli R. Hyperuricemia and renal risk. High Blood Press Cardiovasc Prev. 2014;21(3):189\u201394.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"2","key":"368_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40292-018-0250-7","volume":"25","author":"G Desideri","year":"2018","unstructured":"Desideri G, Virdis A, Casiglia E, Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension. Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, et al. Exploration into uric and cardiovascular disease: uric acid right for heart health (URRAH) project, a study protocol for a retrospective observational study. High Blood Press Cardiovasc Prev. 2018;25(2):197\u2013202.","journal-title":"High Blood Press Cardiovasc Prev."},{"key":"368_CR29","unstructured":"Virdis A, Masi S, Casiglia E et al. Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years. Hypertension. 2019 (Epub ahead of print)."},{"key":"368_CR30","unstructured":"Casiglia E, Tikhonoff V, Virdis A et al. Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA). Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: the URRAH (Uric Acid Right for Heart Health) study. J Hypertens. 2019 (Epub ahead of print)."},{"issue":"7","key":"368_CR31","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.numecd.2014.01.014","volume":"24","author":"G Mul\u00e8","year":"2014","unstructured":"Mul\u00e8 G, Riccobene R, Castiglia A, et al. Relationships between mild hyperuricaemia and aortic stiffness in untreated hypertensive patients. Nutr Metab Cardiovasc Dis. 2014;24(7):744\u201350.","journal-title":"Nutr Metab Cardiovasc Dis."},{"issue":"1","key":"368_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jch.13136","volume":"20","author":"A Maloberti","year":"2018","unstructured":"Maloberti A, Maggioni S, Occhi L, et al. Sex-related relationships between uric acid and target organ damage in hypertension. J Clin Hypertens (Greenwich). 2018;20(1):193\u2013200.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"1","key":"368_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1536\/ihj.13-170","volume":"55","author":"A Yoshimura","year":"2014","unstructured":"Yoshimura A, Adachi H, Hirai Y, et al. Serum uric acid is associated with the left ventricular mass index in males of a general population. Int Heart J. 2014;55(1):65\u201370.","journal-title":"Int Heart J."},{"issue":"4","key":"368_CR34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1536\/ihj.16-359","volume":"58","author":"Y Yamauchi","year":"2017","unstructured":"Yamauchi Y, Fujita SI, Shibata K, et al. Is serum uric acid independently associated with left ventricular mass index, ejection fraction, and B-type natriuretic peptide among female and male cardiac patients? Int Heart J. 2017;58(4):562\u20139.","journal-title":"Int Heart J."},{"key":"368_CR35","doi-asserted-by":"crossref","unstructured":"Antonini-Canterin F, Di Nora C et al. Effect of uric acid serum levels on carotid arterial stiffness and intima-media thickness: a high resolution Echo-Tracking Study. Monaldi Arch Chest Dis. 2019;89(1).","DOI":"10.4081\/monaldi.2019.1007"},{"key":"368_CR36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ajh\/hpw159","volume":"30","author":"C Cuspidi","year":"2017","unstructured":"Cuspidi C, Facchetti R, Bombelli M, et al. Uric acid and new onset left ventricular hypertrophy: findings from the pamela population. Am J Hypertens. 2017;30:279\u201385.","journal-title":"Am J Hypertens"},{"issue":"7","key":"368_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/jch.13603","volume":"21","author":"A Maloberti","year":"2019","unstructured":"Maloberti A, Rebora P, Andreano A, et al. Pulse wave velocity progression over a medium-term follow-up in hypertensives: focus on uric acid. J Clin Hypertens (Greenwich). 2019;21(7):975\u201383.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"2","key":"368_CR38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1161\/HYPERTENSIONAHA.116.08114","volume":"69","author":"M Canepa","year":"2017","unstructured":"Canepa M, Viazzi F, Strait JB, et al. Longitudinal association between serum uric acid and arterial stiffness: results from the baltimore longitudinal study of aging. Hypertension. 2017;69(2):228\u201335.","journal-title":"Hypertension"},{"key":"368_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/nutrit\/nuv111","volume":"74","author":"HP Madlala","year":"2016","unstructured":"Madlala HP, Maarman GJ, Ojuka E. Uric acid and transforming growth factor in fructose-induced production of reactive oxygen species in skeletal muscle. Nutr Rev. 2016;74:259\u201366.","journal-title":"Nutr Rev"},{"key":"368_CR40","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1681\/ASN.2005050572","volume":"16","author":"DH Kang","year":"2005","unstructured":"Kang DH, Park SK, Lee IK. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553\u201362.","journal-title":"J Am Soc Nephrol"},{"key":"368_CR41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.CIR.104.3.346","volume":"104","author":"S Ichihara","year":"2001","unstructured":"Ichihara S, Senbonmatsu T, Price E Jr, et al. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation. 2001;104:346\u201351.","journal-title":"Circulation"},{"key":"368_CR42","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/01.CIR.95.5.1247","volume":"95","author":"T Yokoyama","year":"1997","unstructured":"Yokoyama T, Nakano M, Bednarczyk JL, et al. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation. 1997;95:1247\u201352.","journal-title":"Circulation"},{"key":"368_CR43","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1016\/S0021-9258(18)93017-6","volume":"266","author":"GN Rao","year":"1991","unstructured":"Rao GN, Corson MA, Berk BC. Uric acid stimulates smooth muscle cell proliferation by increasing platelet-derived growth factor a-chain expression. J Biol Chem. 1991;266:8604\u20138.","journal-title":"J Biol Chem"},{"key":"368_CR44","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/annrheumdis-2014-206534","volume":"74","author":"Y Bao","year":"2015","unstructured":"Bao Y, Curhan G, Merriman T, et al. Lack of gene-diuretic interactions on the risk of incident gout: the Nurses\u2019 Health Study and Health Professionals Follow-up Study. Ann Rheum Dis. 2015;74:1394\u20138.","journal-title":"Ann Rheum Dis"},{"key":"368_CR45","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64:1431\u201346.","journal-title":"Arthritis Care Res"},{"key":"368_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/art.33315","volume":"64","author":"MA McAdams DeMarco","year":"2012","unstructured":"McAdams DeMarco MA, Maynard JW, et al. Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study. Arthritis Rheum. 2012;64:121\u20139.","journal-title":"Arthritis Rheum"},{"key":"368_CR47","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ki.1976.63","volume":"9","author":"HW Spencer","year":"1976","unstructured":"Spencer HW, Yarger WE, Robinson RR. Alterations of renal function during dietary-induced hyperuricemia in the rat. Kidney Int. 1976;9:489\u2013500.","journal-title":"Kidney Int"},{"key":"368_CR48","first-page":"F1238","volume":"292","author":"LG Sanchez-Lozada","year":"2007","unstructured":"Sanchez-Lozada LG, Tapia E, Lopez-Molina R, et al. Effects of acute and chronic l-arginine treatment in experimental hyperuricemia. Am J Physiol. 2007;292:F1238\u201344.","journal-title":"Am J Physiol"},{"key":"368_CR49","doi-asserted-by":"publisher","first-page":"C1183","DOI":"10.1152\/ajpcell.00075.2008","volume":"295","author":"S Zharikov","year":"2008","unstructured":"Zharikov S, Krotova K, Hu H, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 2008;295:C1183\u201390.","journal-title":"Am J Physiol Cell Physiol"},{"key":"368_CR50","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.amjcard.2013.12.022","volume":"113","author":"RY Calvo","year":"2014","unstructured":"Calvo RY, Araneta MR, Kritz-Silverstein D, et al. Relation of serum uric acid to severity of and progression of coronary artery calcium in postmenopausal white and Filipino women (from The Rancho Bernardo Study). Am J Cardiol. 2014;113:1153\u20138.","journal-title":"Am J Cardiol"},{"key":"368_CR51","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.numecd.2013.03.005","volume":"23","author":"G Ndrepepa","year":"2013","unstructured":"Ndrepepa G, Cassese S, Braun S, et al. A gender specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutr Metab Cardiovasc Dis. 2013;23:1195\u2013201.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"368_CR52","doi-asserted-by":"publisher","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz M, Johnson T, Sanna S, et al. Meta-analysis of 28141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009;5:e1000504.","journal-title":"PLoS Genet"},{"issue":"9","key":"368_CR53","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/09513590.2015.1056730","volume":"31","author":"S Yu","year":"2015","unstructured":"Yu S, Yang H, Guo X, Zheng L, Sun Y. Hyperuricemia is independently associated with left ventricular hypertrophy in post-menopausal women but not in pre-menopausal women in rural Northeast China. Gynecol Endocrinol. 2015;31(9):736\u201341.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"368_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14728214.2018.1527899","volume":"23","author":"LK Stamp","year":"2018","unstructured":"Stamp LK, Merriman TR, Singh JA. Expert opinion on emerging urate-lowering therapies. Expert Opin Emerg Drugs. 2018;23(3):201\u20139.","journal-title":"Expert Opin Emerg Drugs."},{"key":"368_CR55","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/HYPERTENSIONAHA.114.03953","volume":"64","author":"CJ Beattie","year":"2014","unstructured":"Beattie CJ, et al. Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertension. 2014;64:1102\u20137.","journal-title":"Hypertension"},{"issue":"14","key":"368_CR56","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/heartjnl-2014-305683","volume":"100","author":"P Higgins","year":"2015","unstructured":"Higgins P, Walters MR, Murray HM, McArthur K, McConnachie A, Lees KR, et al. Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart. 2015;100(14):1085\u201392.","journal-title":"Heart"},{"issue":"7","key":"368_CR57","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1681\/ASN.2010111185","volume":"22","author":"MP Kao","year":"2011","unstructured":"Kao MP, Ang DS, Gandy SJ, Nadir MA, Houston JG, Lang CC, et al. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol. 2011;22(7):1382\u20139.","journal-title":"J Am Soc Nephrol"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-020-00368-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-020-00368-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-020-00368-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T22:31:20Z","timestamp":1722551480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-020-00368-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1007\/s40292-020-00368-z","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"14 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All the authors declares that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}